Marra MN[au] - Search Results

Year	Number of Results
1989	2
1990	2
1992	1
1993	3
1994	7
1995	2
1996	2
1997	1
2022	0

1

Antibiotic proteins of human polymorphonuclear leukocytes.

Gabay JE, Scott RW, Campanelli D, Griffith J, Wilde C, Marra MN, Seeger M, Nathan CF. Gabay JE, et al. Among authors: marra mn. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5610-4. doi: 10.1073/pnas.86.14.5610. Proc Natl Acad Sci U S A. 1989. PMID: 2501794 Free PMC article.

2

Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.

Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW. Marra MN, et al. J Immunol. 1990 Jan 15;144(2):662-6. J Immunol. 1990. PMID: 2295804

3

Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats.

Jin H, Yang R, Marsters S, Ashkenazi A, Bunting S, Marra MN, Scott RW, Baker JB. Jin H, et al. Among authors: marra mn. J Clin Invest. 1995 Apr;95(4):1947-52. doi: 10.1172/JCI117877. J Clin Invest. 1995. PMID: 7706502 Free PMC article.

4

Relative concentrations of endotoxin-binding proteins in body fluids during infection.

Opal SM, Palardy JE, Marra MN, Fisher CJ Jr, McKelligon BM, Scott RW. Opal SM, et al. Among authors: marra mn. Lancet. 1994 Aug 13;344(8920):429-31. doi: 10.1016/s0140-6736(94)91767-1. Lancet. 1994. PMID: 7520106

5

Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins.

Marra MN, Thornton MB, Snable JL, Leong S, Lane J, Wilde CG, Scott RW. Marra MN, et al. Blood Purif. 1993;11(2):134-40. doi: 10.1159/000170107. Blood Purif. 1993. PMID: 7506040

6

Activity of lipopolysaccharide-binding protein-bactericidal/permeability-increasing protein fusion peptide in an experimental model of Pseudomonas sepsis.

Opal SM, Palardy JE, Jhung JW, Donsky C, Romulo RL, Parejo N, Marra MN. Opal SM, et al. Among authors: marra mn. Antimicrob Agents Chemother. 1995 Dec;39(12):2813-5. doi: 10.1128/AAC.39.12.2813. Antimicrob Agents Chemother. 1995. PMID: 8593028 Free PMC article.

7

The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.

Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW. Marra MN, et al. J Immunol. 1992 Jan 15;148(2):532-7. J Immunol. 1992. PMID: 1729370

8

Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury.

Arditi M, Zhou J, Huang SH, Luckett PM, Marra MN, Kim KS. Arditi M, et al. Among authors: marra mn. Infect Immun. 1994 Sep;62(9):3930-6. doi: 10.1128/iai.62.9.3930-3936.1994. Infect Immun. 1994. PMID: 8063410 Free PMC article.

9

Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study.

Fisher CJ Jr, Marra MN, Palardy JE, Marchbanks CR, Scott RW, Opal SM. Fisher CJ Jr, et al. Among authors: marra mn. Crit Care Med. 1994 Apr;22(4):553-8. doi: 10.1097/00003246-199404000-00008. Crit Care Med. 1994. PMID: 8143463

10

Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.

Marra MN, Thornton MB, Snable JL, Wilde CG, Scott RW. Marra MN, et al. Crit Care Med. 1994 Apr;22(4):559-65. doi: 10.1097/00003246-199404000-00009. Crit Care Med. 1994. PMID: 8143464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results